NewAmsterdam Pharma Company N.V. Ordinary Shares Tangible Net Worth Ratio

Latest as of September 2025: 99.9%

NewAmsterdam Pharma Company N.V. Ordinary Shares tangible net worth ratio. NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Tangible Net Worth Ratio of 99.9% as of September 2025. This metric is calculated by deducting intangible assets ($439.00K) from net assets ($728.07 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore NewAmsterdam Pharma Company N.V. Ordinar equity growth rate to track the company's year-over-year net asset growth rate.

Tangible NW Ratio

99.9%
Tangible equity / total equity

Net Assets (Equity)

$728.07 Million
USD

Intangible Assets

$439.00K
Goodwill, patents, brand value

Total Assets

$786.43 Million
USD

Tangible Net Worth Ratio of NewAmsterdam Pharma Company N.V. Ordinary Shares (2020–2024)

Tangible net worth ratio of NewAmsterdam Pharma Company N.V. Ordinary Shares from 2020 to 2024. This chart shows how NewAmsterdam Pharma Company N.V. Ordinary Shares's Tangible Net Worth Ratio has changed across 5 annual periods from 2020 to 2024. As of September 2025, the ratio stands at 99.9%, reflecting net assets of $728.07 Million with intangible assets of $439.00K USD. Check how strategically is NewAmsterdam Pharma Company N.V. Ordinar's equity deployed to assess the company's strategic physical and investment asset allocation.

NewAmsterdam Pharma Company N.V. Ordinary Shares Tangible Net Worth Ratio by Year (2020–2024)

NewAmsterdam Pharma Company N.V. Ordinary Shares tangible net worth ratio by year from 2020 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for NewAmsterdam Pharma Company N.V. Ordinary Shares from 2020 to 2024, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see NewAmsterdam Pharma Company N.V. Ordinar (NAMS) market capitalisation.

Year Tangible NW Ratio Net Assets (USD) Intangible Assets Total Assets Change (pp)
2024 99.9% $757.50 Million $534.00K $864.62 Million ▼ 0.0 pp
2023 99.9% $288.39 Million $170.00K $347.10 Million ▼ 0.0 pp
2022 100.0% $430.07 Million $208.00K $478.50 Million ▼ 0.0 pp
2021 100.0% $56.63 Million $0.00 $67.99 Million ▲ +0.0 pp
2020 100.0% $127.46 Million $0.00 $139.87 Million —
pp = percentage points